Personalizing Treatment Targets in Rheumatoid Arthritis by Using a Simple Prediction Model.

CONCLUSION: Presence of anti-CCP, acute-phase response, and erosions at baseline can be used to set individual treatment targets in RA. In patients without these risk factors, a moderate DAS as a target is sufficient, while for patients with all 3 risk factors, a low DAS is not strict enough to limit the risk for joint damage.
PMID: 25593241 [PubMed - as supplied by publisher]

Source: J Rheumatol - January 15, 2015 Category: Rheumatology Authors: de Punder YM, Jansen TL, van Ede AE, den Broeder AA, van Riel PL, Fransen J Tags: J Rheumatol Source Type: research